CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide because of rapid progression and high incidence of metastasis or recurrence. Accumulating evidence shows that CD58-expressing tumor cell is implicated in development of various cancers. The present study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chuanzheng, Cao, Fei, Cao, Jiahao, Jiao, Zhen, You, Yuting, Xiong, Yu, Zhao, Wenxiu, Wang, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422835/
https://www.ncbi.nlm.nih.gov/pubmed/37573318
http://dx.doi.org/10.1186/s12967-023-04364-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422835/
https://www.ncbi.nlm.nih.gov/pubmed/37573318
http://dx.doi.org/10.1186/s12967-023-04364-4

Ejemplares similares